Lantern Pharma Inc.

NASDAQ:LTRN

Biotechnology

Healthcare
$3.93 -4.67%

-$0.19 today

Market cap
$50.14M
Beta
2.32
P/E (TTM)
-2.7
EPS (TTM)
-$1.41
52W Low $1.11High $5.74

Volume 0.10M

Average 0.68M

LTRN Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

No reported Gross Margin figures are available to summarize.

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How LTRN compares with its peers on the latest reported figures

LTRN Competitors Peer median
Gross Margin for LTRN and competitors
Company Period LTM level YoY 3-year change
ATNMActinium Pharmaceuticals, Inc.LTM Jun 2026101.1% —+0.0 pp
RNXTRenovoRx, Inc.LTM Mar 202678.7% +17.9 pp—
LTRNLantern Pharma Inc.FY2025— ——
MAIAMAIA Biotechnology, Inc.FY2025— ——
ANVSAnnovis Bio, Inc.FY2025— ——
Peer median (excluding LTRN) 89.9%+17.9 pp+0.0 pp

Competitors are the stored peer set for LTRN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00174.84K00
Gross Profit00(174.84K)00
Gross Margin—————
Research & Development7.57M8.6M11.89M16.13M11.51M
Selling, General & Admin5.02M5.83M5.98M6.09M6.46M
Operating Expenses12.59M14.43M17.7M22.22M17.98M
Depreciation & Amortization6.76K10.08K174.84K17.28K17.28K
EBITDA(12.36M)(14.05M)(15.79M)(20.76M)(17.1M)
EBITDA Margin—————
Operating Income(12.59M)(14.43M)(17.88M)(22.22M)(17.98M)
Operating Margin—————
Interest Income67.93K204.36K765.39K742.36K437.93K
Interest Expense0204.36K000
Other Income / Expenses228.48K172.81K1.92M1.44M859.06K
Income Before Tax(12.36M)(14.26M)(15.96M)(20.78M)(17.12M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(12.36M)(14.26M)(15.96M)(20.78M)(17.12M)
Net Margin—————
EPS (Basic)(1.13)(1.31)(1.47)(1,930.92)(1.57)
EPS (Diluted)(1.13)(1.31)(1.47)(1,930.92)(1.57)
Weighted Avg Shares10.9M10.85M10.84M10.76M10.9M
Weighted Avg Shares (Diluted)10.9M10.85M10.84M10.76M10.9M

Lantern Pharma Inc.

NASDAQ:LTRN

Intrinsic Alpha fair value

Locked

Current Price

$3.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.